DocGo (DCGO) Stock Forecast & Price Target

DocGo Inc. demonstrates a positive financial outlook characterized by significant year-over-year growth in patient volumes across its core services, including a remarkable 113% increase in home healthcare visits and a 50% rise in telehealth and lab orders. The company has also reported improved economies of scale, achieving an EBITDA of $830,000 with a 20% margin, and has increased its revenue and adjusted EBITDA guidance for 2026 by approximately $10 million, reflecting stronger performance particularly in its transportation segment as staffing levels improve. Furthermore, DocGo's strategic initiatives, such as a 70% patient opt-in rate for primary care after care-gap visits, position the company well for continued growth in its integrated health services.

DocGo Inc. is facing a negative outlook primarily due to a 3% decline in mobile revenue year-over-year and an 8% decline quarter-over-quarter, excluding the impact of acquisitions and specific projects. While the company reported a 47% growth in its non-migrant Mobile Health business, this figure is misleading as it includes a significant contribution from the recent acquisition of SteadyMD, resulting in an implied decline in organic revenue. Furthermore, the company's difficulty in scaling its core Mobile Health services raises concerns about its ability to meet future revenue targets and achieve necessary reductions in operating expenses to support adjusted EBITDA guidance for 2026.